Examining the Efficacy of a Novel Moisturizer Across Eight Weeks

Skin moisture is critical to avoid long-term skin damage. Without the necessary moisture, skin is unlikely to have the properties most commonly associated with healthy skin. Recent research has recently highlighted that rambutan extract, niacinamide, and glycoin can all help promote skin moisture and health. To help people experience better skin health, Thu Brulé has developed a serum designed to be used twice daily. Specifically, the test product in this trial was designed to help moisturize the skin and help lock in that moisture. The purpose of this trial is to examine the efficacy of the test product across an eight-week hybrid trial. The outcomes of interest include participants' perceptions of skin health and photographs/images taken of the skin.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Skin Health

Age range

30 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Citruslabs

Santa Monica, California, 09404, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Male or female between the ages of 30-80.
Frequently experience dry skin.
Must experience early-stage wrinkles that are not treated by topical or oral prescription drugs/medication or over-the-counter products (e.g., Adapalene/Differin)
Must be in good health with no unstable, uncontrolled health conditions.
Must follow a stable, consistent dietary regimen.
May experience hyperpigmentation and dark spots.
Must be willing to maintain the following daily skincare routine: Daily cleansing, test product, and sunscreen that is at least SPF 30
Must discontinue retinoids four weeks before the study start date and not use retinoids during the trial.
Must be willing to communicate in English.
Must be willing to use the test product as directed (twice daily)
Must be willing to come to the Citruslabs office in Santa Monica, California at the beginning and end of the study.

Exclusion criteria

Females who are pregnant or breastfeeding
Currently participating in another research study.
Currently using oral retinoids.
Individuals with self-reported very oily skin.
Individuals with cystic acne or otherwise very acne-prone skin.
Anyone using oral acne treatments (e.g., accutane).
Anyone prone to experiencing strong bouts of hormonal acne.
Anyone using prescription medication relevant to the skin.
Undergoing any cosmetic procedures during the study, including Botox, laser, or chemical peel treatments.
Use of prescription drug (topical or oral) that is targeted at any sort of skin condition (e.g., retinoids)
Anyone with learning and/or cognitive difficulties that prevent him/her from reading and understanding questionnaires and surveys (e.g., dementia)
Severe chronic conditions, including oncological conditions or psychiatric disorders.

Treatment and study plan

Moisturizer

Other

The test product is a novel moisturizer, that contains active ingredients, including rambutan extract, niacinamide, and glycoin.

Primary outcomes

Perceived changes in skin health

Time frame: Week 8

Survey based assessment of participants perceived skin health. Data was collected using a textual 5-point Likert scale for each question, such as "Not noticeable" to "severe." Symptom-related questions were conducted at baseline and each check-in. The textual Likert data was transformed into numerical values of 1-6, with 6 representing the most beneficial response (i.e, "not noticeable" response to the question, "how would you rate the severity of your wrinkles") and 1 representing the least favorable/worse outcome ("severe").
Changes in skin health via VISIA® imaging

Time frame: Baseline to Week 8

VISIA® Skin Analysis system will be used to assess changes in skin outcomes. Analysis will be conducted by a board-certified dermatologist at Baseline and Week 8. The VISIA® Skin Analysis system will be used to capture the images which will then be processed by the VISIA software. The software utilizes advanced algorithms to detect and measure specific skin attributes. The skin attributes/parameters evaluated will be Wrinkles, Spots, Pores, Texture, Redness and UV Damage. These parameters are evaluated using the captured images and the specialized algorithms employed by the VISIA software. The results are then used to generate a comprehensive analysis report, which includes both the quantitative measurements and qualitative assessments, along with any corresponding scores or ratings assigned to different skin attributes. Mean participant's scores for each parameter will be calculated at Baseline and Week 8 and compared for statistical significance.

Sponsors and collaborators

Lead sponsor

Thu Brulé

Industry

Collaborators

Citruslabs

Registry information

Important dates

Study start: 2022
Primary completion: 2023
Study completion: 2023
First posted: May 17, 2023
Registry last updated: May 17, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed